Browsing by Contributors Burnett, Alan K

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 9 of 9
PreviewIssue DateTitleContributor(s)
2015Arsenic trioxide and all- trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups ( AML17 ): results of a randomised , controlled , phase 3 trialBurnett, Alan K; Russell, Nigel H; Hills, Robert K; Bowen, David; Kell, Jonathan; Knapper, Steve; Morgan, Yvonne G; Lok, Jennie; Grech, Angela; Jones, Gail; Infirmary, Leicester Royal
2017CLINICAL TRIALS AND OBSERVATIONS A randomized assessment of adding the kinase inhibitor lestaurtinib to fi rst-line chemotherapy for FLT3-mutated AMLKnapper, Steven; Russell, Nigel; Gilkes, Amanda; Hills, Robert K; Gale, Rosemary E; Cavenagh, James D; Jones, Gail; Kjeldsen, Lars; Grunwald, Michael R; Thomas, Ian; Konig, Heiko; Levis, Mark J; Burnett, Alan K
2017CLINICAL TRIALS AND OBSERVATIONS A randomized assessment of adding the kinase inhibitor lestaurtinib to fi rst-line chemotherapy for FLT3-mutated AMLKnapper, Steven; Russell, Nigel; Gilkes, Amanda; Hills, Robert K; Gale, Rosemary E; Cavenagh, James D; Jones, Gail; Kjeldsen, Lars; Grunwald, Michael R; Thomas, Ian; Konig, Heiko; Levis, Mark J; Burnett, Alan K
2017CLINICAL TRIALS AND OBSERVATIONS A randomized assessment of adding the kinase inhibitor lestaurtinib to fi rst-line chemotherapy for FLT3-mutated AMLKnapper, Steven; Russell, Nigel; Gilkes, Amanda; Hills, Robert K; Gale, Rosemary E; Cavenagh, James D; Jones, Gail; Kjeldsen, Lars; Grunwald, Michael R; Thomas, Ian; Konig, Heiko; Levis, Mark J; Burnett, Alan K
2017CLINICAL TRIALS AND OBSERVATIONS A randomized assessment of adding the kinase inhibitor lestaurtinib to fi rst-line chemotherapy for FLT3-mutated AMLKnapper, Steven; Russell, Nigel; Gilkes, Amanda; Hills, Robert K; Gale, Rosemary E; Cavenagh, James D; Jones, Gail; Kjeldsen, Lars; Grunwald, Michael R; Thomas, Ian; Konig, Heiko; Levis, Mark J; Burnett, Alan K
2016Letters to Blood To the editor :Burnett, Alan K; Russell, Nigel H; Hills, Robert K; Myeloid, Acute; Study, Leukemia; Bowles, K
2015Simpson ’ s Paradox and the Impact of Different DNMT3A Mutations on Outcome in Younger Adults With Acute Myeloid LeukemiaGale, Rosemary E; Lamb, Katarina; Allen, Christopher; El-sharkawi, Dima; Stowe, Cassandra; Jenkinson, Sarah; Tinsley, Steven; Dickson, Glenda; Burnett, Alan K; Hills, Robert K; Linch, David C
2016The value of molecular stratification for CEBPA DM and NPM1 MUT FLT3 WT genotypes in older patients with acute myeloid leukaemiaDickson, Glenda J; Bustraan, Sophia; Hills, Robert K; Ali, Akbar; Goldstone, H; Burnett, Alan K; Linch, C; Gale, Rosemary E
2016The value of molecular stratification for CEBPA(DM) and NPM1(MUT) FLT3(WT) genotypes in older patients with acute myeloid leukaemia.Dickson, Glenda J; Bustraan, Sophia; Hills, Robert K; Ali, Akbar; Goldstone, Anthony H; Burnett, Alan K; Linch, David C; Gale, Rosemary E